Accès ouvert · CC BY

SARS-CoV2 infection in Symptomatic patients: interest of Serological tests and Predictors of Mortality. Experience of DR Congo

Article scientifique 2020 Sciences de la santé Anglais

Résumé

Abstract Background: In symptomatic patients, the diagnostic approach of Covid-19 should be holistic. We aimed to evaluate the concordance between RT-PCR and serological tests (IgM/IgG), and identify the factors that best predict mortality (clinical stages or viral load).Methods: The study included 242 patients referred to the University hospital of Kinshasa for suspected Covid-19, dyspnea or ARDS between June 1st, 2020 and August 02, 2020. Both antibody-SARS-CoV2 IgM/IgG and RT-PCR method were performed on the day of admission to hospital. The clinical stages were established according to the Covid-19 WHO classification. The viral load was expressed by the CtN2 (cycle threshold value of the nucleoproteins) and the CtE (envelope) genes of SARS- CoV-2 detected using GeneXpert. Kappa test and Cox regression were used as appropriate.Results: The GeneXpert was positive in 74 patients (30.6%). Seventy two patients (29.8%) had positive IgM and 34 patients (14.0 %) had positive IgG. The combination of RT-PCR and serological tests made it possible to treat 104 patients as having Covid-19, which represented an increase in cases of around 41% compared to the result based on GeneXpert alone. The comparison between the two tests has shown that 57 patients (23.5 %) had discordant results. The Kappa coefficient was 0.451 (p <0.001). We recorded 23 deaths (22.1 %) among the Covid-19 patients vs 8 deaths (5.8 %) among other patients. The severe-critical clinical stage increased the risk of mortality vs. mild-moderate stage (aHR: 26.8, p < 0.001). The values ​​of CtE and CtN2 did not influence mortality significantly. Conclusion: in symptomatic patients, serological tests are a support which makes it possible to treat a greater number of Covid-19 patients. WHO Clinical classification seems to predict mortality better than SARS-Cov2 viral load.

Citer ce document

Makulo, J., Mandina, M., Mbala, P., Wumba, R., Akilimali, P., Nlandu, Y. M., Odio, J. O., Bepouka, B., Longokolo, M. M., Mukenge, E. K., Kamwiziku, G., Muamba, J. M., Longo, A. L., Lufu, C. M., Keke, H., Mbula, M., Situakibanza, H. N.-T., Sumaili, E. K., & Kayembe, J.-M. (2020). SARS-CoV2 infection in Symptomatic patients: interest of Serological tests and Predictors of Mortality. Experience of DR Congo. Research Square. https://doi.org/10.21203/rs.3.rs-132291/v1

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 05/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 13

Téléchargements (hors robots) : 0

Méthode de comptage